rs549435434
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 10P and 1B. PM2PP5_Very_StrongBP4
The NM_000360.4(TH):c.-71C>T variant causes a upstream gene change. The variant allele was found at a frequency of 0.0000116 in 1,462,176 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000360.4 upstream_gene
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TH | NM_000360.4 | c.-71C>T | upstream_gene_variant | ENST00000352909.8 | NP_000351.2 | |||
TH | NM_199292.3 | c.-71C>T | upstream_gene_variant | NP_954986.2 | ||||
TH | NM_199293.3 | c.-71C>T | upstream_gene_variant | NP_954987.2 | ||||
TH | XM_011520335.3 | c.-71C>T | upstream_gene_variant | XP_011518637.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152126Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000992 AC: 13AN: 1309932Hom.: 0 Cov.: 18 AF XY: 0.00000767 AC XY: 5AN XY: 651468
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152244Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74438
ClinVar
Submissions by phenotype
Autosomal recessive DOPA responsive dystonia Pathogenic:6
Variant summary: TH c.-71C>T alters a conserved nucleotide located within the cAMP response element (CRE) in the untranscribed region upstream of the TH gene. The variant was absent in 31334 control chromosomes. c.-71C>T has been reported in the literature as homozygous or compound heterozygous genotypes in multiple individuals affected with Segawa Syndrome, Autosomal Recessive (DOPA-responsive dystonia) (example, Verbeek_2007, Ribases_2007, Stamelou_2012). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in a reduction of 90% of basal transcription of the TH promotor in-vitro (Tinti_1997). The following publications have been ascertained in the context of this evaluation (PMID: 32872068, 25910213, 17698383, 22815559, 17696123, 9235905). Three submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
- -
- -
- -
This variant occurs in a non-coding region of the TH gene. It does not change the encoded amino acid sequence of the TH protein. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individuals with TH-related conditions and dystonia (PMID: 17696123, 17698383, 22815559). It has also been observed to segregate with disease in related individuals. This variant is also known as c.1-71 C>T. ClinVar contains an entry for this variant (Variation ID: 558656). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this variant affects TH function (PMID: 9235905, 25910213). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at